Cover Image

Mu-opioid receptor expression in multibacillary leprosy

<p>Background: During the clinical course of multibacillary leprosy disease, mainly in Lepromatous Leprosy (LL) patients, acute and systemic inflammatory episodes known as Erythema Nodosum Leprosum (ENL) may be present. The histology of ENL skin lesions initially shows hyperplasia of epidermis...

Full description

Saved in:

Bibliographic Details
Main Authors:	Patrícia Elizabeth Pignataro (Author), Leonardo Pereira Quintella (Author), Helen Ferreira (Author), Adelaide Lopes Amorim (Author), Roberta Olmo Pinheiro (Author), Luiz Claudio Ferreira (Author), Francisco das Chagas de Carvalho Rodrigues (Author), Maria Inês Fernandes Pimentel (Author)
Format:	Book
Published:	Open Journal of Tropical Medicine - Peertechz Publications, 2019-12-31.
Subjects:	Research Article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Blood coagulation abnormalities in multibacillary leprosy patients.
by: Débora Santos da Silva, et al.
Published: (2018)

Study of the µ opioid receptor in cutaneous ulcers of leishmaniasis and sporotrichosis according to the complaints of local pain
by: Patrícia Elizabeth Pignataro, et al.
Published: (2019)

Multibacillary leprosy unmasked by COVID-19 vaccination
by: Shashendra Aponso, MD, MRCP, et al.
Published: (2022)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
by: Keith M. Olson, et al.
Published: (2023)

Comparing the clinical and histological diagnosis of leprosy and leprosy reactions in the INFIR cohort of Indian patients with multibacillary leprosy.
by: Diana N J Lockwood, et al.
Published: (2012)

Comment on "Multibacillary leprosy unmasked by COVID-19 vaccination"
by: Vinod Hanumanthu, MD, et al.
Published: (2022)

Multibacillary Leprosy Presenting as Anetoderma in a Young Teenager
by: Niraj Parajuli, et al.
Published: (2020)

Treatment of multibacillary leprosy following the development of dapsone hypersensitivity syndrome
by: Sudarsono
Published: (2019)

Pauci- and Multibacillary Leprosy: Two Distinct, Genetically Neglected Diseases.
by: Jean Gaschignard, et al.
Published: (2016)

The impact of KIR/HLA genes on the risk of developing multibacillary leprosy.
by: Hugo Vicentin Alves, et al.
Published: (2019)

A Case Report of Multibacillary Leprosy Presenting with Multiple Outbreaks of Erythema Nodosum Leprosum
by: R. Bouceiro-Mendes, et al.
Published: (2019)

Multibacillary leprosy by population groups in Brazil: Lessons from an observational study.
by: Mauricio Lisboa Nobre, et al.
Published: (2017)

Development of Predictive Index for Default Treatment At Multibacillary Leprosy in District Sampang
by: Muhammad Syarif Rukua, et al.
Published: (2015)

Trends of leprosy and multibacillary infection in the state of Georgia since the early 1900s.
by: Carter D McCormick, et al.
Published: (2019)

Functional selectivity of EM-2 analogs at the mu-opioid receptor
by: Justyna Piekielna-Ciesielska, et al.
Published: (2023)

Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
by: Muzeyyen Ugur, et al.
Published: (2018)

The Demography, Clinical Characteristics, and White Blood Analysis of Leprosy Reactions in Multibacillary Leprosy: A Retrospective Study
by: Natalia Tanojo, et al.
Published: (2021)

It's MORe exciting than mu: Crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system
by: Elena H Chartoff, et al.
Published: (2014)

Social school contacts of multibacillary leprosy cases in children living in the hyperendemic region of the Midwest of Brazil
by: Camila Massae Sato, et al.
Published: (2022)

Atypical erythema nodosum leprosum as the presenting feature in multibacillary leprosy: A case report
by: Sanchaita Bala, et al.
Published: (2014)

Suspected resistance of MDT-MB in Multibacillary Leprosy of Hansen's disease: Two case reports
by: Yudo Irawan, et al.
Published: (2016)

NFκB activation in cutaneous lesions of leprosy is associated with development of multibacillary infection
by: Wambier CG, et al.
Published: (2014)

A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism
by: Wentworth Sean, et al.
Published: (2010)

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
by: Pergolizzi JV Jr, et al.
Published: (2020)

A masquerading solitary skin lesion: Unusual presentation of multibacillary leprosy with dermoscopic assistance in diagnosis
by: Naveen Kumar Kansal, et al.
Published: (2020)

Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
by: Joshua C. Zamora, et al.
Published: (2021)

Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment
by: Imen CHATTI, et al.
Published: (2017)

Use of an inertial sensor and a force platform to assess static balance in participants affected by multibacillary leprosy.
by: Aymee Lobato Brito, et al.
Published: (2024)

Higher Level Zinc Serum in Multibacillary Leprosy With Erythema Nodosum Leprosum compared to Patients Without Reaction
by: Kinanti Prabawaningrum, et al.
Published: (2016)

Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl
by: Xiangyun Tian, et al.
Published: (2022)

Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
by: Li Zhang, et al.
Published: (2020)

Monoclonal antibody targeting mu-opioid receptor attenuates morphine tolerance via enhancing morphine-induced receptor endocytosis
by: Jia-Jia Zhang, et al.
Published: (2023)

Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
by: Alba Vidal-Torres, et al.
Published: (2023)

Analgesic tone conferred by constitutively active mu opioid receptors in mice lacking β-arrestin 2
by: Hales Tim G, et al.
Published: (2011)

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
by: Zachary W. Reichenbach, et al.
Published: (2022)

Effectiveness of the retreatment of patients with multibacillary leprosy and episodes of erythema nodosum leprosum and/or persistent neuritis: a single-center experience
by: Joel Carlos Lastória, et al.
Published: (2018)

Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent
by: Tay GK, et al.
Published: (2012)

Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid  dependence: A meta-analysis
by: Janet K Coller, et al.
Published: (2009)

In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
by: Roberta Lattanzi, et al.
Published: (2018)

Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons - Effects of Nerve Injury
by: Philip Stötzner, et al.
Published: (2018)